Lipopeptide vaccines (EQiTX)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLipopeptide vaccines (EQiTX)
Drug Alias NameVacTX
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHypersensitivityAutoimmune DiseasesProstatic Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEqitx
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHypersensitivityAutoimmune DiseasesProstatic Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A